Kaneka Of Japan To Buy Majority Of Eurogentec For Biopharma Entry
This article was originally published in PharmAsia News
Executive Summary
Japan's Kaneka, a contract manufacturer of pharmaceuticals, said it intends to buy a majority share of Belgium's Eurogentec, maker of biologics for biopharmaceuticals, for about $44 million